In a cohort of mastocytosis patients, they also reported a high prevalence of HαT in SM (12.2%—10/82) and, similar to our study, an increased risk for severe systemic anaphylaxis within this group of HαT-positive SM patients. This evidence concerns the gene TMPRSS11D and systemic mastocytosis.